Hint mode is switched on Switch off

MMCB, ordinary share
GEMA, RU000A100GC7, 1-01-85932-H

Add a stock to WL
Choose all Reset all
MMCB, сountry — Russia
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Dividends

Issuer

Profile
International Medical Center for Processing and Cryopreservation of Biomaterials PJSC was established by Human Stem Cells Institute PJSC in October 2014 to carry out activities on personal banking of hematopoietic stem cells of umbilical cord blood ...
International Medical Center for Processing and Cryopreservation of Biomaterials PJSC was established by Human Stem Cells Institute PJSC in October 2014 to carry out activities on personal banking of hematopoietic stem cells of umbilical cord blood and other valuable biomaterials. The spin-off into a subsidiary was made in order to more efficiently manage the business of Gemabank, created by HSCI in 2003, as well as to use state incentives for taxing the profits of medical companies. Gemabank is a licensed bank for personal storage of umbilical cord blood cells and umbilical cord. It complies with the requirements of international GMP standards. The transfer of Gemabank's activities to the "IMCB" PJSC began in 2015 after the appropriate licensing.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    International Medical Center for Processing and Cryopreservation of Biomaterials PJSC
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Planned
  • Subscription type
    Open
  • Placement exchange
    ***
  • Ticker
    GEMA
  • Placement
    19.06.2026 - 30.06.2026
  • Number of papers
    3,370,080
  • Volume of raised funds
    -
  • Final placement price
    -
  • Price change since placement date
    0%
Authorization required
You need to request access

IFRS/US GAAP reports

2022
II q NTL
IV q NTL
2021
II q NTL
IV q NTL
2020
IV q NTL
2019
IV q NTL
2018
IV q NTL
Show all Hide

Related Stock indices

Related entities on 01/08/2023

Have shares in the company

In which the company has interests

Indicators

Authorization required
You need to request access

Issuer's quarterly reports/RAS Reports

2026
I q NTL
2025
I q NTL
II q NTL
III q NTL
IV q NTL
2024
I q NTL
II q NTL
III q NTL
IV q NTL
2023
I q NTL
II q NTL
III q NTL
IV q NTL
2022
I q NTL
II q NTL
III q NTL
IV q NTL
2021
I q NTL
II q NTL
III q NTL
IV q NTL
2020
I q NTL
II q NTL
III q NTL
IV q NTL
2019
I q NTL
II q NTL
III q NTL
IV q NTL
2018
IV q NTL
2017
IV q NTL
2016
IV q NTL
Show all Hide

Annual reports

2025
IV q NTL
2024
IV q NTL
2023
IV q NTL
2022
IV q NTL
Show all Hide
Authorization required
You need to request access

News

30/07/2021 MMCB announces about increased RAS net profit for 6 months of 2021, up 16.77% YoY. Total revenue’s increase is 14.02%
03/05/2021 RAS. MMCB. March 31, 2021: long-term liabilities’ increase is 9.96 % YoY
02/04/2021 MMCB announces decreased RAS net profit for 2020, down 2.95 % YoY
14/04/2020 MMCB’s 4 Q 2019 Y IFRS results were published
30/03/2020 Gazprom’s, VimpelCom’s, Transneft’s, Rossium’s, Mediaholding’s, VEB-Leasing’s, Western High-Speed Diameter’s, Human Stem Cell Institute’s 4 Q 2019 Y RAS results were published
All organization news

Domestic and international bonds of the issuer

Holders

Industry Leaders

Registration is required to get access.